Becton, Dickinson and Company (BDX) , popularly known as BD, recently received the FDA's approval for the use of self-collected vaginal specimens for human papillomavirus (HPV) testing when cervical specimens cannot otherwise be obtained. The approval is expected to enable women to self-collect vaginal specimens for HPV testing in a healthcare setting, including non-traditional locations such as retail pharmacies or mobile clinics. Per estimates, HPV is the cause of virtually all cervical cancer and HPV tes ...